Professor Brendan Crabb at the recent launch of the Sir Zelman Cowen Fellowship Fund in Canberra.
Burnet Institute Director and CEO, Professor Brendan Crabb has been elected President of the Association of Australian Medical Research Institutes (AAMRI) and will lead the organisation for the next two years as the medical research sector faces some of the most significant strategic challenges to its future.
AAMRI is the peak body for Australia’s 41 independent medical research institutes, which collectively manage an estimated $700 million in health and medical research funds each year, and employ more than 8,000 staff and students.
Professor Crabb is also a research scientist with expertise in the study of infectious diseases, particularly those affecting the developing world.
His own special interest is the development of a malaria vaccine and the identification of new targets for therapeutic intervention.
In this regards, he is the current Chair of the US-based Malaria Vaccine Science Portfolio Advisory committee, the oversight group for the major vaccines under clinical development.
Professor Crabb said he was honoured to be elected to lead AAMRI at such a pivotal time for Australian medical research.
“We have a big job ahead of us with the government’s review of the medical research sector due later this year and ongoing pressure on research budgets,” he said.
“Australia has an incredibly vibrant, productive and talented research community and we punch well above our weight in medical research, but there’s work to be done if we want to retain our position on the international stage.
“Investment in a strong health and medical research sector is an investment in the health and wealth of all Australians.”